ALT Level 73 in Fatty Liver Disease: How Serious Is It?

When ALT levels reach 73 in individuals with fatty liver disease, it typically indicates that the condition has progressed to non-alcoholic fatty liver disease (NAFLD) or even non-alcoholic steatohepatitis (NASH). This stage is considered significant and should not be ignored, as it suggests that liver cells are not only accumulating fat but also experiencing inflammation and damage.

Fatty liver disease progresses through several stages: simple fatty liver, fatty liver with inflammation (steatohepatitis), fibrosis, and eventually cirrhosis. Elevated ALT levels are a key indicator of liver inflammation, which means the liver is under stress and undergoing cellular injury. If left untreated, this inflammation can lead to fibrosis and ultimately cirrhosis, which is irreversible and increases the risk of liver failure or liver cancer.

There are several common causes of fatty liver disease, including excessive calorie intake, obesity—especially abdominal obesity—alcohol consumption, and certain medications such as corticosteroids and amiodarone. Medical conditions like inflammatory bowel disease and polycystic ovary syndrome (PCOS) can also contribute to the development of fatty liver.

When ALT levels rise due to fatty liver disease, it's crucial to address the root cause. Lifestyle changes such as weight loss, a balanced diet, and regular physical activity are essential. In addition, patients may benefit from medications that reduce liver inflammation and support liver function. Avoiding alcohol and reassessing any potentially harmful medications is also vital.

Early detection and intervention can halt or even reverse the progression of fatty liver disease. Regular monitoring of liver enzymes and overall liver health is highly recommended for those at risk or already diagnosed with elevated ALT levels.